DELCATH SYSTEMS
Delcath Systems and its proprietary targeted drug delivery system are at the forefront of the regional treatment of cancer. The Company's technology, known as Percutaneous Hepatic Perfusion (PHP), allows physicians to deliver significantly higher doses of anti-cancer drugs to the site of disease without exposing the patient's entire body to those same potent levels of drug. Initial clinical results from studies treating cancer in the liver confirm that delivering more drug to the tumor site, and less to the other regions of the body, enhances tumor shrinkage with improved quality of life over systemic cancer therapies. PHP is currently undergoing testing in Phase III and Phase II clinical trials for a variety of cancers of the liver.
DELCATH SYSTEMS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1987-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.delcath.com
Total Employee:
11+
Status:
Active
Contact:
2124892102
Email Addresses:
[email protected]
Total Funding:
143.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon WordPress Apache Sitelinks Search Box Microsoft Exchange Online Organization Schema
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
EpiVax
EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Current Employees Featured
Stock Details
Investors List
Avenue Capital Group
Avenue Capital Group investment in Post-IPO Debt - Delcath Systems
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Delcath Systems
Official Site Inspections
http://www.delcath.com Semrush global rank: 7.75 M Semrush visits lastest month: 437
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
